Phibro Animal Health PAHC
NASDAQ PAHC
$34.45 -0.85 (-2.41%)
As of: Sep 17, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026)

Phibro Animal Health (PAHC) posted Non-Current Debt of $591.8 million for Q2 2026, down 0.99% on a QoQ basis from $597.7 million in Q1 2026, and down 3.85% year-over-year from $615.4 million in Q2 2025.

Analysis

Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Non-Current Debt for 14 years, with the latest figure at $591.8 million in Q2 2026.

  • On a quarterly basis, Non-Current Debt fell 3.85% year-over-year to $591.8 million in Q2 2026; TTM through Jun 2026 was $591.8 million, a 3.85% decrease from a year earlier, with the FY2026 full-year figure at $591.8 million, down 3.85% from the prior year.
  • Non-Current Debt was $591.8 million for Q2 2026 at Phibro Animal Health, down from $597.7 million in the prior quarter.
  • The five-year high for Non-Current Debt was $622.9 million in Q4 2024, with the low at $272.9 million in Q2 2022.
  • Average Non-Current Debt over 5 years is $412.0 million, with a median of $301.3 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt decreased 9.39% in 2024, then jumped 118.02% in 2025.
  • Over 5 years, Non-Current Debt stood at $276.8 million in 2022, then increased by 7.6% to $297.9 million in 2023, then soared by 109.12% to $622.9 million in 2024, then dropped by 3.09% to $603.6 million in 2025, then dropped by 1.96% to $591.8 million in 2026.
  • The last three Non-Current Debt figures came in at $591.8 million (Q2 2026), $597.7 million (Q1 2026), and $603.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn 299.87 Mn
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn 9.05 Bn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn 3.85 Bn
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 591.77 Mn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn 8.30 Mn
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - 1.25 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 591.77 Mn
Mar 31, 2026 597.69 Mn
Dec 31, 2025 603.60 Mn
Sep 30, 2025 609.52 Mn
Jun 30, 2025 615.44 Mn
Mar 31, 2025 619.16 Mn
Dec 31, 2024 622.88 Mn
Sep 30, 2024 287.67 Mn
Jun 30, 2024 282.29 Mn
Mar 31, 2024 291.01 Mn
Dec 31, 2023 297.85 Mn
Sep 30, 2023 304.72 Mn
Jun 30, 2023 311.54 Mn
Mar 31, 2023 273.02 Mn
Dec 31, 2022 276.81 Mn
Sep 30, 2022 280.74 Mn
Jun 30, 2022 272.93 Mn
Mar 31, 2022 276.62 Mn
Dec 31, 2021 280.32 Mn
Sep 30, 2021 284.01 Mn